Bedeutung der Lipidtherapie bei Diabetes

作者: Christoph H. Saely , Heinz Drexel

DOI: 10.1007/S10354-010-0745-X

关键词:

摘要: LDL cholesterol plays a central role in atherogenesis and lowering statin therapy significantly reduces cardiovascular risk patients with diabetes. Therefore, current guidelines is the primary target of lipid intervention. All type 2 diabetes should reach an <100 mg/dl, very-high both coronary artery disease <70 mg/dl. Given overwhelming body evidence for efficacy respect to event prevention, primarily be lowered by statins. Many will require high-dose meet stringent treatment goal Importantly, typically exhibit pattern dyslipidemia high triglycerides, low HDL cholesterol, small, atherogenic particles, which strong predictor vascular events Despite currently limited from large clinical endpoint-trials additional this diabetic niacin or fibrates therefore appears promising option at least combination disease.

参考文章(27)
Christoph H. Saely, Bernd Eber, Karl P. Pfeiffer, Heinz Drexel, Low serum LDL cholesterol in patients with type 2 diabetes: an analysis on two different patient populations. International Journal of Cardiology. ,vol. 144, pp. 394- 398 ,(2010) , 10.1016/J.IJCARD.2009.04.048
Sanjiv J. Shah, David D. Waters, Philip Barter, John J.P. Kastelein, James Shepherd, Nanette K. Wenger, David A. DeMicco, Andrei Breazna, John C. LaRosa, Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery. Journal of the American College of Cardiology. ,vol. 51, pp. 1938- 1943 ,(2008) , 10.1016/J.JACC.2007.12.054
A. Michael Lincoff, Kathy Wolski, Stephen J. Nicholls, Steven E. Nissen, Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus JAMA. ,vol. 298, pp. 1180- 1188 ,(2007) , 10.1001/JAMA.298.10.1180
P Rein, S Beer, C Saely, A Vonbank, H Drexel, Abstract: P1337 PREVALENCE OF IMPAIRED GLUCOSE METABOLISM IN INDIVIDUALS WITH PERIPHERAL ARTERIAL DISEASE Atherosclerosis Supplements. ,vol. 10, ,(2009) , 10.1016/S1567-5688(09)71354-6
Patricia M Kearney, Anthony Keech, John Simes, Rory Collins, Colin Baigent, None, Statins and diabetes – Authors' reply The Lancet. ,vol. 371, pp. 1752- 1752 ,(2008) , 10.1016/S0140-6736(08)60761-8
Philipp Rein, Stefan Beer, Christoph H. Saely, Alexander Vonbank, Heinz Drexel, Prevalence of impaired glucose metabolism in individuals with peripheral arterial disease International Journal of Cardiology. ,vol. 144, pp. 243- 244 ,(2010) , 10.1016/J.IJCARD.2009.01.002
Michael Davidson, Peter M. Meyer, Steven Haffner, Steven Feinstein, Ralph D’Agostino, George T. Kondos, Alfonso Perez, Zhen Chen, Theodore Mazzone, Increased High-Density Lipoprotein Cholesterol Predicts the Pioglitazone-Mediated Reduction of Carotid Intima-Media Thickness Progression in Patients With Type 2 Diabetes Mellitus Circulation. ,vol. 117, pp. 2123- 2130 ,(2008) , 10.1161/CIRCULATIONAHA.107.746610
Rory Collins, Jane Armitage, Sarah Parish, Peter Sleight, Richard Peto, Heart Protection Study The Lancet. ,vol. 361, pp. 529- 530 ,(2003) , 10.1016/S0140-6736(03)12475-0